TY - JOUR T1 - Association of advance care planning with place of death and utilisation of life-sustaining treatments in deceased patients at Taipei City Hospital in Taiwan JF - BMJ Supportive & Palliative Care JO - BMJ Support Palliat Care SP - e311 LP - e318 DO - 10.1136/bmjspcare-2020-002520 VL - 12 IS - e3 AU - Yung-Feng Yen AU - Ya-Ling Lee AU - Hsiao-Yun Hu AU - Wen-Jung Sun AU - Ming-Chung Ko AU - Shen-Shong Chang AU - Chu-Chieh Chen AU - Sheng-Jean Huang AU - Dachen Chu Y1 - 2022/08/01 UR - http://spcare.bmj.com/content/12/e3/e311.abstract N2 - Objective Evidence is mixed regarding the impact of advance care planning (ACP) on place of death. This cohort study investigated the effect of ACP programmes on place of death and utilisation of life-sustaining treatments for patients during end-of-life (EOL) care.Methods This prospective cohort study identified deceased patients between 2015 and 2016 at Taipei City Hospital. ACP was determined by patients’ medical records and defined as a process to discuss patients’ preferences with respect to EOL treatments and place of death. Place of death included hospital or home death. Stepwise logistic regression determined the association of ACP with place of death and utilisation of life-sustaining treatments during EOL care.Results Of the 3196 deceased patients, the overall mean age was 78.6 years, and 46.5% of the subjects had an ACP communication with healthcare providers before death. During the study follow-up period, 166 individuals died at home, including 98 (6.59%) patients with ACP and 68 (3.98%) patients without ACP. After adjusting for sociodemographic factors and comorbidities, patients with ACP were more likely to die at home during EOL care (adjusted OR (AOR)=1.71, 95% CI 1.24 to 2.35). Moreover, patients with ACP were less likely to receive cardiopulmonary resuscitation (AOR 0.36, 95% CI 0.25 to 0.51) as well as intubation and mechanical ventilation support (AOR 0.54, 95% CI 0.44 to 0.67) during the last 3 months of life.Conclusion Patients with ACP were more likely to die at home and less likely to receive life-sustaining treatments during EOL care.Data are available on reasonable request. This prospective cohort study analysed the palliative data at Taipei City Hospital. All information that allows a specific individual patient to be identified was encrypted. After encryption of the data, we collected patients’ demographics, comorbidities, place of death and life-sustaining treatments during EOL care. ER -